⌘K

Home/Filings/4/0000950170-24-034350

4//SEC Filing

Waksal Harlan 4

Accession 0000950170-24-034350

CIK 0001327273other

View on SEC.gov Company Profile

Filed

Mar 19, 8:00 PM ET

Accepted

Mar 20, 7:21 PM ET

Size

5.0 KB

Accession

0000950170-24-034350

Insider Transaction Report

Form 4

Period: 2024-03-18

Lyra Therapeutics, Inc.LYRA

DirectorExecutive Chair

Transactions

Award
Common Stock
2024-03-18+275,000→ 536,966 total

Footnotes (1)

[F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest in full on January 31, 2025.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Lyra Therapeutics, Inc.

CIK 0001327273

Entity typeother

Related Parties

1

filerCIK 0001449008

Filing Metadata

Form type: 4
Filed: Mar 19, 8:00 PM ET
Accepted: Mar 20, 7:21 PM ET
Size: 5.0 KB

View on SEC.gov